Core Viewpoint - The 2025 Frontiers in Life Genomics Technology and Translation Conference was held in Nanjing, focusing on "technological innovation driving omics applications" and showcasing advancements in the life genomics field [1][3]. Group 1: Event Overview - The conference was co-hosted by Nanjing Zhenmai Biotechnology Co., Ltd. and Shenzhen Zhenmai Biotechnology Co., Ltd., featuring top scholars and industry leaders discussing cutting-edge technologies and their translation paths [1][3]. - The event emphasized four dimensions: frontier technology, scenario application, biometry, and achievement transformation, aiming to bridge the gap from innovation to implementation [3]. Group 2: Product Launches - Zhenmai Biotechnology launched three innovative products, including a high-throughput nucleic acid fragment analyzer, which addresses the long-standing reliance on imports in this field [1][5]. - The high-throughput nucleic acid fragment analyzer serves as a core device for "preoperative examination" in gene sequencing, enhancing sample library quality checks and increasing detection success rates [5][6]. Group 3: Technological Innovations - The CMS chemical technology introduced by Zhenmai achieves an error rate as low as 0.001%, enhancing the performance and reducing costs for applications requiring high precision, such as tumor early screening and organ transplant rejection monitoring [6]. - The spatial omics chip combines the functions of a "microscope" and a "sequencer," allowing precise recording of molecular positions within tissues, which aids in tumor research and Alzheimer's disease studies [6]. Group 4: Industry Impact - Zhenmai has established a comprehensive product array covering low, medium, high, and ultra-high throughput sequencing instruments, achieving 100% domestic production of core components and materials [8]. - The conference facilitated connections between research institutions, medical organizations, and enterprises, accelerating the validation and promotion of innovative technologies [8].

Group 1 - The development of the Anji Economic Development Zone relies heavily on talent, particularly in the fields of biotechnology and semiconductor industries [1] - Anji has established a targeted talent recruitment mechanism to address industry needs and has organized various recruitment events, successfully attracting 1,011 young graduates in the first half of the year [1] - The development zone provides comprehensive support to companies, including housing and education policies, to facilitate talent acquisition [1] Group 2 - Talent project introduction is crucial for sustaining industrial growth in Anji, with a focus on attracting high-quality talent projects through strategic partnerships and innovation competitions [2] - The establishment of Saitu Gene Technology (Anji) Co., Ltd. highlights the successful attraction of innovative companies, which aim to provide next-generation molecular pathology solutions [2] - Saitu Gene plans to expand its production capacity, potentially generating an additional 40 million yuan in sales after the completion of new production lines [2] Group 3 - The Anji Economic Development Zone is fostering a vibrant innovation ecosystem, with companies like Xinshi Bio and Kairuisi Medical leading advancements in biotechnology and molecular detection platforms [3] - The development zone aims to implement a strategy focused on innovation and talent cultivation, enhancing its position as a source of innovation and talent reservoir [3]